Meeting
2019 ASCO Quality Care Symposium
Outcomes and care patterns for advanced pancreatic cancer patients treated in tertiary vs regional/community cancer centres in Northern Alberta.
Authors
Matthew Anaka
University of Alberta, Edmonton, AB, Canada
Matthew Anaka, Minji Lee, Sunita Ghosh, Winson Y. Cheung, Jennifer L. Spratlin
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cost, Value, and Policy; Health Equity and Disparities
Track
Cost, Value, and Policy,Health Care Access, Equity, and Disparities
Sub Track
Health Disparities
Citation
J Clin Oncol 37, 2019 (suppl 27; abstr 163)
DOI
10.1200/JCO.2019.37.27_suppl.163
Abstract #
163
Poster Bd #
R2
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
First-line chemotherapy regimens associated with survival in advanced pancreatic cancer: A Mexican single-center, real-world study.
First Author: Marytere Herrera
Poster
2019 Gastrointestinal Cancers Symposium
Impact of new chemotherapy regimens on the treatment landscape and survival of advanced pancreatic cancer (PAC) patients (pts).
First Author: Markus Kieler
Poster
2014 Gastrointestinal Cancers Symposium
Second-line gemcitabine plus nab-paclitaxel (G+A) for advanced pancreatic cancer (APC) after first-line FOLFIRINOX: Single institution retrospective review of efficacy and toxicity.
First Author: Yue Zhang
Poster
2024 ASCO Breakthrough
Predicting chemotherapy response in patients with advanced or metastatic pancreatic cancer using machine learning.
First Author: Moonho Kim